Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Effects of radiolabelled monoclonal antibody infusion on blood leukocytes in cancer patients

Journal Article · · Journal of Clinical Laboratory Analysis; (USA)
; ;  [1]
  1. Loma Linda Univ./Independent Order of Foresters Cancer Research Laboratory, CA (USA)
This study was undertaken to investigate the effects of a single infusion of radiolabelled murine monoclonal antibody (MAb) on peripheral blood leukocytes in cancer patients. Eleven patients with disseminated colon cancer, malignant melanoma, or lung adenocarcinoma were infused with 111In-labelled anti-ZCE 025, anti-p97 type 96.5c, or LA 20207 MAb, respectively. Blood samples were obtained before infusion, immediately after infusion (1 hr), and at 4 and 7 days postinfusion. Flow cytometry analysis of CD3+, CD4+, CD8+, CD16+, and CD19+ lymphocytes showed increasing CD4:CD8 ratios in seven patients after infusion. This phenomenon was not restricted to antibody subclass or to type of cancer. Two of the remaining patients exhibited a marked post-infusion increase in CD8+ cells. In all three patients with malignant melanoma, decreasing levels of CD16+ lymphocytes were noted after infusion and natural killer cell cytotoxicity showed fluctuations which paralleled the changes in the CD16+ subpopulation. Oxygen radical production by phagocytic cells was markedly affected in three subjects. These results suggest that a single infusion of radiolabelled murine MAb may alter the balance of critical lymphocyte subpopulations and modulate other leukocyte responses in cancer patients.
OSTI ID:
6808901
Journal Information:
Journal of Clinical Laboratory Analysis; (USA), Journal Name: Journal of Clinical Laboratory Analysis; (USA) Vol. 4:1; ISSN JCANE; ISSN 0887-8013
Country of Publication:
United States
Language:
English